Increased Protein and Lipid Oxidative Damage in Mitochondria Isolated from Lymphocytes from Patients with Alzheimer's Disease: Insights into the Role of Oxidative Stress in Alzheimer's Disease and Initial Investigations into a Potential Biomarker for this Dementing Disorder
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is histopathologically characterized by the presence of senile plaques, neurofibrillary tangles, and synapse loss. The main component of senile plaques is amyloid β-peptide (Aβ), which has been shown to induce oxidative stress in in vitro and in vivo studies. AD is associated with elevated levels of oxidative damage in brain and peripheral lymphocytes. Further Aβ has been found to be accumulated in mitochondria, which might contribute to the reported alterations in the mitochondrial morphology, and impaired mitochondrial energy metabolism in AD brain. Biomarkers are desperately needed for earlier diagnosis of AD and to monitor efficacy of new therapies. Hence, in the present study we show that markers of oxidative damage are elevated in mitochondria isolated from AD lymphocytes suggesting that these oxidative stress indices potentially could serve as a viable biomarker for AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“mitochondria isolated from lymphocytes from persons with AD and MCI showed elevated oxidative damage that correlated inversely with cognitive performance [36,37].”
From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [36]
In the citing paper
“Redox proteomics identified similar proteins as identified in AD and MCI brains as oxidatively modified, and these included mitochondrial ATP synthase [36,37].”
From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [36]
In the citing paper
“Levels of protein-bound carbonyls, 3-NT, and HNE are significantly increased in mitochondria isolated from lymphocytes of MCI and AD patients, which correlate with elevated Aβ levels, decreased levels of small molecule antioxidants, and decreased cognitive test performance [36,37].”
From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [36]
In the citing paper
“The connection between AD and T-cell function was reported for neuronal signaling and AD pathology (4,47).”
From Alzheimer's Disease–Associated Amyloid-β Precursor Protein Prevents Aging Stress–Induced Mitophagy and Fumarate Depletion to Improve Antitumor Immunity (2025) · cites this paper as [47]
In the citing paper
“AD patients are predisposed to some complications including increased oxidative stress (Sultana et al., 2011), morbidity, mortality (Schelke et al., 2016), microvascular disease, dyslipidemia, and insulin resistance (Sridhar et al., 2015).”
From Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial (2016) · cites this paper as Sultana et al., 2011
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Protein Oxidation in Aging, Disease, and Oxidative Stress
Berlett, B. S., & Stadtman, E. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20313 · Cited by 3,332
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease
Caspersen, C., Wang, N., Yao, J., Sosunov, A., Chen, X., Lustbader, J. W., Xu, H. W., Stern, D., McKhann, G., & Du Yan, S. (2005) · The FASEB Journal · doi:10.1096/fj.05-3735fje · Cited by 738 · cited 2×
“Alterations in the mitochondrial morphology and impaired mitochondrial energy metabolism have been well documented in AD brain [18, 20, 41].”
ALLANBUTTERFIELD, D., CASTEGNA, A., LAUDERBACK, C., & DRAKE, J. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00340-2 · Cited by 715
Markesbery, W. R., & Lovell, M. A. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00009-8 · Cited by 680
Mitochondrial abnormalities in Alzheimer brain: Mechanistic implications
Bubber, P., Haroutunian, V., Fisch, G., Blass, J. P., & Gibson, G. E. (2005) · Annals of Neurology · doi:10.1002/ana.20474 · Cited by 622
Cited by
Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease
Tönnies, E., & Trushina, E. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161088 · Cited by 1,750
Akbari, E., Asemi, Z., Daneshvar Kakhaki, R., Bahmani, F., Kouchaki, E., Tamtaji, O. R., Hamidi, G. A., & Salami, M. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00256 · Cited by 946
The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates
Franceschi, C., Garagnani, P., Morsiani, C., Conte, M., Santoro, A., Grignolio, A., Monti, D., Capri, M., & Salvioli, S. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00061 · Cited by 945
“Elevated levels of oxidative stress markers are also present in mitochondria isolated from peripheral lymphocytes of AD patients (141).”
BackgroundLee, W.-H., Loo, C.-Y., Bebawy, M., Luk, F., Mason, R., & Rohanizadeh, R. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311040002 · Cited by 537
Butterfield, D. A., Swomley, A. M., & Sultana, R. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5027 · Cited by 526
Self-citationButterfield, D. A., & Boyd-Kimball, D. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170543 · Cited by 403
Self-citationElevation of glutathione as a therapeutic strategy in Alzheimer disease
Pocernich, C. B., & Butterfield, D. A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.003 · Cited by 346
Self-citationExercise benefits on Alzheimer’s disease: State-of-the-science
Valenzuela, P. L., Castillo-García, A., Morales, J. S., de la Villa, P., Hampel, H., Emanuele, E., Lista, S., & Lucia, A. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101108 · Cited by 337
Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: A meta-analysis
Schrag, M., Mueller, C., Zabel, M., Crofton, A., Kirsch, W. M., Ghribi, O., Squitti, R., & Perry, G. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.07.005 · Cited by 336
Oxidative stress, protein modification and Alzheimer disease
Tramutola, A., Lanzillotta, C., Perluigi, M., & Butterfield, D. A. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.06.005 · Cited by 303
Self-citationPerluigi, M., Di Domenico, F., & Butterfield, D. A. (2024) · Physiological Reviews · doi:10.1152/physrev.00030.2022 · Cited by 282
Self-citationMecocci, P., Boccardi, V., Cecchetti, R., Bastiani, P., Scamosci, M., Ruggiero, C., & Baroni, M. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170732 · Cited by 256
Self-citationVitamin C, Aging and Alzheimer’s Disease
Monacelli, F., Acquarone, E., Giannotti, C., Borghi, R., & Nencioni, A. (2017) · Nutrients · doi:10.3390/nu9070670 · Cited by 243
“Oxidative stress interacts with multiple features associated with AD pathogenesis, such as APP processing, mitochondrial dysfunction, and metal accumulation [80].”
BackgroundDen, H., Dong, X., Chen, M., & Zou, Z. (2020) · Aging · doi:10.18632/aging.102810 · Cited by 230
Oxidant/Antioxidant Imbalance in Alzheimer’s Disease: Therapeutic and Diagnostic Prospects
Wojsiat, J., Zoltowska, K. M., Laskowska-Kaszub, K., & Wojda, U. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6435861 · Cited by 221
Oxidative Stress in Alzheimer’s Disease: Are We Connecting the Dots?: Miniperspective
Rosini, M., Simoni, E., Milelli, A., Minarini, A., & Melchiorre, C. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm400970m · Cited by 201
Mitochondrial genes are altered in blood early in Alzheimer's disease
Lunnon, K., Keohane, A., Pidsley, R., Newhouse, S., Riddoch-Contreras, J., Thubron, E. B., Devall, M., Soininen, H., Kłoszewska, I., Mecocci, P., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.12.029 · Cited by 190
“…in the periphery including in platelets (Bosetti et al., 2002; Cardoso et al., 2004; Parker et al., 1990; Valla et al., 2006) and white blood cells from AD patients (Feldhaus et al., 2011; Lunnon et al., 2012, 2013; Mecocci et al., 1998, 2002; Sultana et al., 2011, 2013; Wang et al., 2006).”
BackgroundSelf-citationAbeta, oxidative stress in Alzheimer disease: Evidence based on proteomics studies
Swomley, A. M., Förster, S., Keeney, J. T., Triplett, J., Zhang, Z., Sultana, R., & Butterfield, D. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.015 · Cited by 189
Self-citationNeuroprotective Role of Trans-Resveratrol in a Murine Model of Familial Alzheimer's Disease
Porquet, D., Griñán-Ferré, C., Ferrer, I., Camins, A., Sanfeliu, C., del Valle, J., & Pallàs, M. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-140444 · Cited by 177
Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease
Unzeta, M., Esteban, G., Bolea, I., Fogel, W. A., Ramsay, R. R., Youdim, M. B. H., Tipton, K. F., & Marco-Contelles, J. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00205 · Cited by 144
Redox Proteomics in Selected Neurodegenerative Disorders: From Its Infancy to Future Applications
Butterfield, D. A., Perluigi, M., Reed, T., Muharib, T., Hughes, C. P., Robinson, R. A. S., & Sultana, R. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4109 · Cited by 168
Self-citationMitochondrial Dysfunction and Immune Activation are Detectable in Early Alzheimer's Disease Blood
Lunnon, K., on behalf of the AddNeuroMed Consortium, Ibrahim, Z., Proitsi, P., Lourdusamy, A., Newhouse, S., Sattlecker, M., Furney, S., Saleem, M., Soininen, H., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111592 · Cited by 144
Self-citationConnecting the “Dots”: From Free Radical Lipid Autoxidation to Cell Pathology and Disease
Foret, M. K., Lincoln, R., Carmo, S. D., Cuello, A. C., & Cosa, G. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00761 · Cited by 156
Peripheral Mitochondrial Dysfunction in Alzheimer’s Disease: Focus on Lymphocytes
Leuner, K., Schulz, K. L., Schuett, T., Pantel, J., Prvulovic, D., Rhein, V. F., Savaskan, E., Czech, C., Eckert, A., & Müller, W. E. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8300-y · Cited by 143
García-Mesa, Y., Colie, S., Corpas, R., Cristòfol, R., Comellas, F., Nebreda, A. R., Giménez-Llort, L., & Sanfeliu, C. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv005 · Cited by 124
A systematic review of minor phytocannabinoids with promising neuroprotective potential
Stone, N. L., Murphy, A. J., England, T. J., & O’Sullivan, S. E. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15185 · Cited by 142
Wang, Z., Wang, C., Yuan, B., Liu, L., Zhang, H., Zhu, M., Chai, H., Peng, J., Huang, Y. H., Zhou, S., et al. (2025) · Microbiome · doi:10.1186/s40168-024-02001-w · Cited by 132
Butterfield, D. A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.006 · Cited by 126
Self-citationDynamics of Human Mitochondrial Complex I Assembly: Implications for Neurodegenerative Diseases
Giachin, G., Bouverot, R., Acajjaoui, S., Pantalone, S., & Soler‐López, M. (2016) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2016.00043 · Cited by 128
Oxidative modification of lipoic acid by HNE in Alzheimer disease brain
Hardas, S. S., Sultana, R., Clark, A. M., Beckett, T. L., Szweda, L. I., Murphy, M. P., & Butterfield, D. A. (2013) · Redox Biology · doi:10.1016/j.redox.2013.01.002 · Cited by 120
“Then the membrane was subsequently incubated with primary antibody (1:2000) followed by HRP-conjugated secondary antibody as described previously [25,26] for the detection of the HNE-LA levels.”
MethodSelf-citationOxidative Stress in Alzheimer’s Disease: Should We Keep Trying Antioxidant Therapies?
Ferreira, M. E. S., de Vasconcelos, A. S., Vilhena, T. D. C., da Silva, T. L., Barbosa, A. D. S., Gomes, A. R. Q., Dolabela, M. F., & Percário, S. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0157-y · Cited by 117
Di Domenico, F., Barone, E., Perluigi, M., & Butterfield, D. A. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6759 · Cited by 114
Self-citationKraska, A., Santin, M. D., Dorieux, O., Joseph-Mathurin, N., Bourrin, E., Petit, F., Jan, C., Chaigneau, M., Hantraye, P., Lestage, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046196 · Cited by 103
Strategy to reduce free radical species in Alzheimer’s disease: an update of selected antioxidants
Di Domenico, F., Barone, E., Perluigi, M., & Butterfield, D. A. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.955853 · Cited by 102
Self-citationZou, Y. S., Hong, B., Fan, L., Zhou, L., Liu, Y., Wu, Q., Zhang, X., & Dong, M. (2012) · Free Radical Research · doi:10.3109/10715762.2012.742518 · Cited by 111
Peng, Y., Gao, P., Shi, L., Chen, L., Liu, J., & Long, J. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7763 · Cited by 110
Butterfield, D. A. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101049 · Cited by 93
Self-citationRedox proteomics and amyloid β-peptide: Insights into Alzheimer disease
Butterfield, D. A., & Boyd‐Kimball, D. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14589 · Cited by 105
Self-citationNaturally Occurring Antioxidant Therapy in Alzheimer’s Disease
Collins, A. E., Saleh, T. M., & Kalisch, B. E. (2022) · Antioxidants · doi:10.3390/antiox11020213 · Cited by 102
Glutathione as a Redox Biomarker in Mitochondrial Disease—Implications for Therapy
Enns, G. M., & Cowan, T. M. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6050050 · Cited by 101
Uddin, M. S., Al Mamun, A., Kabir, M. T., Ashraf, G. M., Bin-Jumah, M. N., & Abdel-Daim, M. M. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02116-9 · Cited by 86
“Moreover, there is also presence of altered concentrations of antioxidant enzymes in certain AD brain areas [55, 56].”
BackgroundMitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease
Butterfield, D. A., & Boyd-Kimball, D. (2020) · Antioxidants · doi:10.3390/antiox9090818 · Cited by 85
“Moreover, mitochondria isolated from lymphocytes from persons with AD and MCI showed elevated oxidative damage that correlated inversely with cognitive performance [36,37].”
BackgroundSelf-citationAscorbic acid, cognitive function, and Alzheimer's disease: A current review and future direction
Bowman, G. L. (2012) · BioFactors · doi:10.1002/biof.1002 · Cited by 66
ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy
Marco-Contelles, J., Unzeta, M., Bolea, I., Esteban, G., Ramsay, R. R., Romero, A., Martínez-Murillo, R., Carreiras, M. C., & Ismaili, L. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00294 · Cited by 75
Mangialasche, F., Westman, E., Kivipelto, M., Muehlboeck, J. ‐., Cecchetti, R., Baglioni, M., Tarducci, R., Gobbi, G., Floridi, P., Soininen, H., et al. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12037 · Cited by 67
Self-citationOxidative Damage of DNA as Early Marker of Alzheimer’s Disease
Peña-Bautista, C., Tirle, T., López-Nogueroles, M., Vento, M., Baquero, M., & Cháfer-Pericás, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246136 · Cited by 71
Circulating biomarkers of protein oxidation for Alzheimer disease: Expectations within limits
Domenico, F. D., Coccia, R., Butterfield, D. A., & Perluigi, M. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.10.001 · Cited by 73
Self-citationA quantitative meta-analysis of vitamin C in the pathophysiology of Alzheimer’s disease
Hamid, M., Mansoor, S., Amber, S., & Zahid, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.970263 · Cited by 71
Oxidative Stress and Its Clinical Applications in Dementia
Mao, P. (2013) · Journal of Neurodegenerative Diseases · doi:10.1155/2013/319898 · Cited by 52
Sultana, R., Baglioni, M., Cecchetti, R., Cai, J., Klein, J. B., Bastiani, P., Ruggiero, C., Mecocci, P., & Butterfield, D. A. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.08.001 · Cited by 64
“Previous studies from our laboratory showed that the mitochondria isolated from AD lymphocytes showed increased markers of oxidative stress, and the oxidative stress inversely correlated with MMSE score [25].”
Self-citationMolecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer’s Disease
Mamun, A. A., Uddin, M. S., Bin Bashar, M. F., Zaman, S., Begum, Y., Bulbul, I. J., Islam, M. S., Sarwar, M. S., Mathew, B., Amran, M. S., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5086250 · Cited by 53
Oxidative Stress and Aberrant Cell Cycle in Alzheimer’s Disease Lymphocytes: Diagnostic Prospects
Wojsiat, J., Prandelli, C., Laskowska-Kaszub, K., Martín-Requero, A., & Wojda, U. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-141977 · Cited by 54
Apaijai, N., Sriwichaiin, S., Phrommintikul, A., Jaiwongkam, T., Kerdphoo, S., Chansirikarnjana, S., Thongmung, N., Mahantassanapong, U., Vathesatogkit, P., Kitiyakara, C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-78551-4 · Cited by 60
Perspectives on Oxidative Stress in Alzheimer’s Disease and Predictions of Future Research Emphases
Butterfield, D. A. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179912 · Cited by 55
Self-citationThe development of effective biomarkers for Alzheimer's disease: a review
Henry, M. S., Passmore, A. P., Todd, S., McGuinness, B., Craig, D., & Johnston, J. A. (2013) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3829 · Cited by 49
Boyko, A., Troyanova, N. I., Kovalenko, E. I., & Sapozhnikov, A. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122633 · Cited by 57
Mangialasche, F., Baglioni, M., Cecchetti, R., Kivipelto, M., Ruggiero, C., Piobbico, D., Kussmaul, L., Monastero, R., Brancorsini, S., & Mecocci, P. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142052 · Cited by 53
Self-citationIn vivo target bio-imaging of Alzheimer's disease by fluorescent zinc oxide nanoclusters
Lai, L., Zhao, C., Su, M., Li, X., Liu, X., Jiang, H., Amatore, C. A., & Wang, X. (2016) · Biomaterials Science · doi:10.1039/c6bm00233a · Cited by 52
Zweig, J. A., Brandes, M. S., Brumbach, B. H., Caruso, M. A., Wright, K. M., Quinn, J. F., Soumyanath, A., & Gray, N. E. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210271 · Cited by 51
One-carbon epigenetics and redox biology of neurodegeneration
Coppedè, F. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.002 · Cited by 46
Huang, H., Zhang, Z., & Wu, H. (2016) · Pharmacognosy Magazine · doi:10.4103/0973-1296.182174 · Cited by 43
Mitochondrial dysfunction and cellular metabolic deficiency in Alzheimer’s disease
Gu, X., Huang, H., & Jiang, Z.-F. (2012) · Neuroscience Bulletin · doi:10.1007/s12264-012-1270-2 · Cited by 42
Sultana, R., Robinson, R. A. S., Di Domenico, F., Abdul, H. M., Clair, D. K. S., Markesbery, W. R., Cai, J., Pierce, W. M., & Butterfield, D. A. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.06.015 · Cited by 41
Self-citationFinelli, M. J. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00254 · Cited by 40
Anand, S., Barnes, J. M., Young, S. A., Garcia, D. M., Tolley, H. D., Kauwe, J. S. K., & Graves, S. W. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170035 · Cited by 31
Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease
Mezeiová, E., Chalupova, K., Nepovimová, E., Górecki, L., Prchal, L., Maliňák, D., Kuča, K., Soukup, O., & Korábečný, J. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190228122956 · Cited by 36
Emerging insights into the role of albumin with plasma exchange in Alzheimer’s disease management
Costa, M., & Páez, A. (2021) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2021.103164 · Cited by 33
Alzheimer Disease: The Role of Aβ in the Glutamatergic System
Campos‐Peña, V., & Antônio, M. (2014) · InTech eBooks · doi:10.5772/57367 · Cited by 33
Martins, W. C., dos Santos, V. V., dos Santos, A. A., Vandresen-Filho, S., Dal-Cim, T. A., de Oliveira, K. A., Nedel, C. B., Farina, M., Prediger, R. D., Viola, G. G., et al. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9527-y · Cited by 31
Mitochondrial quality control in the brain: The physiological and pathological roles
Shen, X., Sun, P., Zhang, H., & Yang, H. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1075141 · Cited by 31
Effects of Curcumin and Boric Acid Against Neurodegenerative Damage Induced by Amyloid Beta (1-42)
Hacıoğlu, C., Kar, F., Kar, E., Kara, Y., & Kanbak, G. (2020) · Biological Trace Element Research · doi:10.1007/s12011-020-02511-2 · Cited by 29
Carmona, P., Molina, M., Calero, M., Bermejo‐Pareja, F., Martínez‐Martín, P., Álvarez, I., & Tolédano, A. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-5669-9 · Cited by 27
Marcinkowska, M., Bucki, A., Panek, D., Siwek, A., Fajkis-Zajączkowska, N., Bednarski, M., Zygmunt, M., Godyń, J., Valdivieso, Á. D. R., Kotańska, M., et al. (2019) · Archiv der Pharmazie · doi:10.1002/ardp.201900041 · Cited by 27
Butterfield, D. A., Palmieri, E. M., & Castegna, A. (2016) · Expert Review of Proteomics · doi:10.1586/14789450.2016.1149470 · Cited by 27
Self-citationTramutola, A., Abate, G., Lanzillotta, C., Triani, F., Barone, E., Iavarone, F., Vincenzoni, F., Castagnola, M., Marziano, M., Memo, M., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.414 · Cited by 26
Self-citationDifferential processing of amyloid precursor protein in brain and in peripheral blood leukocytes
Delvaux, E., Bentley, K., Stubbs, V., Sabbagh, M., & Coleman, P. D. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.004 · Cited by 26
“Although there have been studies of specific subclasses of PBL in AD, particularly lymphocytes (e.g. Sultana et al., 2011; Stieler et al., 2012), we did not distinguish among Neurobiol Aging.”
BackgroundPachón-Angona, I., Martin, H., Chhor, S., Oset‐Gasque, M. J., Refouvelet, B., Marco, J. L., & Ismaïli, L. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0191 · Cited by 24
Ying, M., Sui, X., Zhang, Y., Sun, Q., Qu, Z., Luo, X., Chang, R. C., Ni, J., Liu, J., & Yang, X. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9959-2 · Cited by 24
Dynamic Interplay between Copper Toxicity and Mitochondrial Dysfunction in Alzheimer’s Disease
Tassone, G., Kola, A., Valensin, D., & Pozzi, C. (2021) · Life · doi:10.3390/life11050386 · Cited by 22
Lymphocytes in Alzheimer's Disease Pathology: Altered Signaling Pathways
Esteras, N., Alquézar, C., de la Encarnación, A., & Martín‐Requero, Á. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666151116124912 · Cited by 22
Maruthiyodan, S., Mumbrekar, K. D., & Guruprasad, K. P. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101868 · Cited by 21
Darras, F. H., Kling, B., Sawatzky, E., Heilmann, J., & Decker, M. W. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.06.010 · Cited by 21
Overexpression of Cell Cycle Proteins of Peripheral Lymphocytes in Patients with Alzheimer's Disease
Kim, H. R., Kwon, Y.-A., Ahn, I. S., Kim, S., Kim, S., Jo, S. A., & Kim, D. K. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.1.127 · Cited by 20
Özdemir, Ç., Arslan, M., Küçük, A., Yığman, Z., & Dursun, A. D. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s405963 · Cited by 19
Mamun, A. A., Pidaný, F., Hulcová, D., Maříková, J., Kučera, T., Schmidt, M., Catapano, M. C., Hrabinová, M., Jun, D., Múčková, Ľ., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158308 · Cited by 18
Macchi, B., Marino‐Merlo, F., Frezza, C., Cuzzocrea, S., & Mastino, A. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8641-9 · Cited by 17
Hu, A., Li, F., Guo, L., Zhao, X., & Xiang, X. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s380353 · Cited by 16
Bhullar, K. S., & Rupasinghe, H. P. V. (2015) · Food Research International · doi:10.1016/j.foodres.2015.05.019 · Cited by 16
Esteban, G., Schoors, J. V., Sun, P., Eeckhaut, A. V., Marco, J. L., Smolders, I. J., & Unzeta, M. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12697 · Cited by 15
Mancini, G., Martins, W. C., de Oliveira, J., Bem, A. F. D., & Tasca, C. I. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02026-w · Cited by 13
Kassir, M. F., Lee, H. G., Oleinik, N. V., Wofford, W., Walton, C., Atilgan, F. C., Janneh, A. H., Chakraborty, P., Calisir, K., Percin, E., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-4740 · Cited by 10
Xiang, C., Lu, Y., Hao, R., Wei, Y., Hu, Y., & Yu, G. (2024) · PubMed Central · doi:10.22038/ijbms.2024.78543.16982 · Cited by 10
Chen, B., Wang, Q., Wang, Y., Liu, Q., Chen, W., Mao, H., Li, J., Liu, Q., & Zhou, X. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1695681 · Cited by 8
Li, Z., Wu, H., Ji, Y., Shi, Z., Liu, S., Bao, X., Shan, P., Hu, D., & Li, M. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230248 · Cited by 8
Hao, E., Qin, J., Wei, W., Miao, J., Xie, Y., Pan, X., Hangxuan, W., Xie, J., Fan, X., Du, Z., et al. (2020) · Journal of Analytical Methods in Chemistry · doi:10.1155/2020/5165631 · Cited by 8
Guzmán, R., Campos, C., Yuguero, R., Masegù, C., Gil, P., & Moragón, Á. C. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.04.006 · Cited by 8
Gedaly, R., Orozco, G., Lewis, L. J., Valvi, D., Chapelin, F., Khurana, A., Hidalgo, G. E., Shmookler, A. D., Tripathi, A., Zhang, C., et al. (2024) · American Journal of Transplantation · doi:10.1016/j.ajt.2024.10.024 · Cited by 5
The multifaceted role of mitochondrial dysfunction in Alzheimer’s disease pathogenesis
Ebrahimi, R., Mohammadi, I., Ghafourian, K., Firouzabadi, S. R., Saleh, M., Davoody, S., Azad, G., & Esmaeilpour, K. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01850-8 · Cited by 4
Perspectives on the Role of APOE4 as a Therapeutic Target for Alzheimer’s Disease
Patel, K., Srivastava, S., Kushwah, S., & Mani, A. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210027 · Cited by 4
Neuroprotection of Thioredoxin1 in the Brain
Noriega‐Navarro, R., Martinez-Tapia, R. J., Osornio-Hernández, J. L., Landa‐Navarro, L., Xinastle-Castillo, L. O., Landa, A., & Navarro, L. (2023) · Current Alzheimer Research · doi:10.2174/1567205020666230809145041 · Cited by 3
Metadata
- Authors
- Sultana, R., Mecocci, P., Mangialasche, F., Cecchetti, R., Baglioni, M., & Butterfield, D. A.
- Affiliations
- Department of Chemistry, Centre of Membrane Sciences, and Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA
- University of Perugia (IT)
- University of Kentucky (US)
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2011-03-29
- Volume
- 24
- Issue
- 1
- Pages
- 77-84
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2100692887
- Cited by
- 111
- References
- 53
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 5 · 2021: 6 · 2020: 15 · 2019: 6 · 2018: 8 · 2017: 7 · 2016: 12 · 2015: 7 · 2014: 7 · 2013: 9 · 2012: 10
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P01AG005119, AG0 5119)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- Alzheimer's disease, oxidative stress
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Female, Humans, Lymphocytes, Male, Mitochondria, Lipid Peroxidation, Biomarkers, Oxidative Stress, Protein Carbonylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.